Supercede Therapeutics

Fudan University and East China Normal University (ECNU) have entered into a global rights cooperation agreement with Supercede Therapeutics, a small-molecule start-up, to develop a novel drug aimed at anti-tumor cachexia and muscle enhancement. Under the terms of the agreement, Supercede will secure the global development and commercialization rights for…